Cleary Gottlieb represented Biomet, Inc. in the refinancing of its existing Euro-denominated extended term loans and US dollar-denominated extended term loans with the proceeds of new US dollar-denominated term loans with improved pricing. The transaction closed on September 25, 2013.
Biomet designs, manufactures and markets a diverse portfolio of reconstructive, fixation and other products used primarily by musculoskeletal medical specialists.
